Welcome to LookChem.com Sign In|Join Free
  • or
4-[N-(3,3-diphenylpropyl)-N-methylamino]-2-butanone, also known as 4-[(3,3-diphenylpropyl)methylamino]-2-butanone, is a synthetic organic compound with the molecular formula C21H25NO. It is a derivative of 2-butanone, featuring a methylamino group attached to the 4-position and a 3,3-diphenylpropyl group connected to the nitrogen atom. 4-[N-(3,3-diphenylpropyl)-N-methylamino]-2-butanone is known for its psychoactive properties and has been studied for its effects on the central nervous system. It is important to note that the compound is not approved for medical use and is subject to legal restrictions due to its potential for abuse and health risks.

100427-47-2

Post Buying Request

100427-47-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

100427-47-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 100427-47-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,4,2 and 7 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 100427-47:
(8*1)+(7*0)+(6*0)+(5*4)+(4*2)+(3*7)+(2*4)+(1*7)=72
72 % 10 = 2
So 100427-47-2 is a valid CAS Registry Number.

100427-47-2Downstream Products

100427-47-2Relevant academic research and scientific papers

Asymmetric N-(3,3-diphenylpropyl)aminoalkyl esters of 4-aryl-2,6- dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acids with antihypertensive activity

Leonardi, Amedeo,Motta, Gianni,Pennini, Renzo,Testa, Rodolfo,Sironi, Giorgio,Catto, Alberto,Cerri, Alberto,Zappa, Marco,Bianchi, Giorgio,Nardi, Dante

, p. 399 - 420 (1998)

A series of asymmetric 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates characterized by the presence of a 3,3-diphenylpropylamino moiety in one of the ester groups were synthesized. They exhibited remarkable antihypertensive activity in spontaneously hypertensive rats as well as affinity for the 1,4- dihydropyridines binding site labelled by 3H-nitrendipine in the calcium channel. Introduction of this bulky and lipophilic amine confers to the whole series an elevated level of antihypertensive activity and a long duration of action, a structure-dependent modulation of the activity being found only in the subset characterized by the presence of a branched propylene bridge between the ester and the amino groups. The presence of the amino group is essential for oral activity. Out of this series, compound 9u (Rec 15/2375- lercanidipine) was selected for clinical development and obtained marketing authorization as an antihypertensive in several countries.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 100427-47-2